238 related articles for article (PubMed ID: 20021456)
1. The effects of current therapies on airway remodeling in asthma and new possibilities for treatment and prevention.
Royce SG; Tang ML
Curr Mol Pharmacol; 2009 Jun; 2(2):169-81. PubMed ID: 20021456
[TBL] [Abstract][Full Text] [Related]
2. Impact of inhaled corticosteroids and leukotriene receptor antagonists on airway remodeling.
Hoshino M
Clin Rev Allergy Immunol; 2004 Aug; 27(1):59-64. PubMed ID: 15347851
[TBL] [Abstract][Full Text] [Related]
3. What effect does asthma treatment have on airway remodeling? Current perspectives.
Durrani SR; Viswanathan RK; Busse WW
J Allergy Clin Immunol; 2011 Sep; 128(3):439-48; quiz 449-50. PubMed ID: 21752441
[TBL] [Abstract][Full Text] [Related]
4. Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma.
Lee HY; Rhee CK; Kang JY; Park CK; Lee SY; Kwon SS; Kim YK; Yoon HK
Korean J Intern Med; 2016 Jan; 31(1):89-97. PubMed ID: 26767862
[TBL] [Abstract][Full Text] [Related]
5. The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling.
Hur J; Kang JY; Rhee CK; Kim YK; Lee SY
Pulm Pharmacol Ther; 2018 Feb; 48():5-14. PubMed ID: 29031615
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma.
Banno A; Reddy AT; Lakshmi SP; Reddy RC
Clin Sci (Lond); 2020 May; 134(9):1063-1079. PubMed ID: 32369100
[TBL] [Abstract][Full Text] [Related]
7. Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice.
Royce SG; Dang W; Yuan G; Tran J; El-Osta A; Karagiannis TC; Tang ML
Arch Immunol Ther Exp (Warsz); 2012 Aug; 60(4):295-306. PubMed ID: 22684086
[TBL] [Abstract][Full Text] [Related]
8. Asthma therapy and airway remodeling.
Mauad T; Bel EH; Sterk PJ
J Allergy Clin Immunol; 2007 Nov; 120(5):997-1009; quiz 1010-1. PubMed ID: 17681364
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroids and antigen avoidance decrease airway smooth muscle mass in an equine asthma model.
Leclere M; Lavoie-Lamoureux A; Joubert P; Relave F; Setlakwe EL; Beauchamp G; Couture C; Martin JG; Lavoie JP
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):589-96. PubMed ID: 22721832
[TBL] [Abstract][Full Text] [Related]
10. Airway remodelling in asthma: current understanding and implications for future therapies.
Tang ML; Wilson JW; Stewart AG; Royce SG
Pharmacol Ther; 2006 Nov; 112(2):474-88. PubMed ID: 16759709
[TBL] [Abstract][Full Text] [Related]
11. Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2-induced airway inflammation and remodeling.
Tabeling C; Herbert J; Hocke AC; Lamb DJ; Wollin SL; Erb KJ; Boiarina E; Movassagh H; Scheffel J; Doehn JM; Hippenstiel S; Maurer M; Gounni AS; Kuebler WM; Suttorp N; Witzenrath M
Allergy; 2017 Jul; 72(7):1061-1072. PubMed ID: 27906453
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease.
Royce SG; Dang W; Ververis K; De Sampayo N; El-Osta A; Tang ML; Karagiannis TC
Epigenetics; 2011 Dec; 6(12):1463-70. PubMed ID: 22139576
[TBL] [Abstract][Full Text] [Related]
13. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of histone deacetylase inhibitors in a murine asthma model.
Ren Y; Su X; Kong L; Li M; Zhao X; Yu N; Kang J
Inflamm Res; 2016 Dec; 65(12):995-1008. PubMed ID: 27565183
[TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptor-gamma on airway smooth muscle thickening in a murine model of chronic asthma.
Rhee CK; Lee SY; Kang JY; Kim SJ; Kwon SS; Kim YK; Park SH
Int Arch Allergy Immunol; 2009; 148(4):289-96. PubMed ID: 19001788
[TBL] [Abstract][Full Text] [Related]
16. Can anti-IgE therapy prevent airway remodeling in allergic asthma?
Rabe KF; Calhoun WJ; Smith N; Jimenez P
Allergy; 2011 Sep; 66(9):1142-51. PubMed ID: 21645010
[TBL] [Abstract][Full Text] [Related]
17. A novel prostacyclin agonist protects against airway hyperresponsiveness and remodeling in mice.
Yamabayashi C; Koya T; Kagamu H; Kawakami H; Kimura Y; Furukawa T; Sakagami T; Hasegawa T; Sakai Y; Matsumoto K; Nakayama M; Gelfand EW; Suzuki E; Narita I
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):170-7. PubMed ID: 22403804
[TBL] [Abstract][Full Text] [Related]
18. [Future perspectives in the therapy of asthma in children].
Tosca MA; Villa E; Rossi GA
Minerva Pediatr; 2008 Apr; 60(2):235-47. PubMed ID: 18449140
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and remodeling in the adult and child with asthma.
Jeffery P
Pediatr Pulmonol Suppl; 2001; 21():3-16. PubMed ID: 11475169
[TBL] [Abstract][Full Text] [Related]
20. Review: Pharmacological treatment of airway remodeling: inhaled corticosteroids or antileukotrienes?
Riccioni G; Di Ilio C; D'Orazio N
Ann Clin Lab Sci; 2004; 34(2):138-42. PubMed ID: 15228224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]